-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
West Pharmaceutical Services Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2011 to Q4 2024.
- West Pharmaceutical Services Inc Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $4.3M, a 207% increase year-over-year.
- West Pharmaceutical Services Inc Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $18.7M, a 19.7% decline year-over-year.
- West Pharmaceutical Services Inc annual Share-based Payment Arrangement, Expense for 2024 was $18.7M, a 19.7% decline from 2023.
- West Pharmaceutical Services Inc annual Share-based Payment Arrangement, Expense for 2023 was $23.3M, a 1.69% decline from 2022.
- West Pharmaceutical Services Inc annual Share-based Payment Arrangement, Expense for 2022 was $23.7M, a 36.8% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)